Deepak Nagra
Overview
Explore the profile of Deepak Nagra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel S, Yang Z, Nagra D, Adas M, Russell M, Norton S, et al.
Lupus Sci Med
. 2025 Feb;
12(1).
PMID: 39933822
Objectives: Ethnicity and health outcomes are intrinsically interrelated, although mechanisms are complex. SLE is a disease with higher incidence in Asian, Black, Hispanic and Indigenous populations than in White populations....
2.
Nagra D, Bechman K, Russell M, Yang Z, Adas M, Molbanti H, et al.
Rheumatology (Oxford)
. 2024 Jun;
PMID: 38833673
Introduction: Current guidelines recommend pneumococcal vaccination in individuals who are over the age of 65 or are immunosuppressed due to a disease or treatment. The objective of this study was...
3.
Russell M, Yang Z, Walter B, Alveyn E, Bechman K, Miracle A, et al.
Lancet Rheumatol
. 2024 Feb;
6(3):e138-e139.
PMID: 38310922
No abstract available.
4.
Russell M, Massey J, Roddy E, Mackenna B, Bacon S, Goldacre B, et al.
Lancet Rheumatol
. 2024 Jan;
5(10):e622-e632.
PMID: 38251486
Background: Gout is the most prevalent inflammatory arthritis, yet one of the worst managed. Our objective was to assess how the COVID-19 pandemic impacted incidence and quality of care for...
5.
Nagra D, Bechman K, Russell M, Yang Z, Adas M, Subesinghe S, et al.
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38250882
Vaccination against pneumococcus reduces the risk of infective events, hospitalisation, and death in individual with inflammatory arthritis, particularly in those on immunomodulating therapy who are at risk of worse outcomes...
6.
Bechman K, Yang Z, Adas M, Nagra D, S Uguzlar A, Russell M, et al.
Arthritis Rheumatol
. 2023 Dec;
76(5):704-714.
PMID: 38116697
Objective: Anterior uveitis is a common extra-articular manifestation of axial spondyloarthritis (AxSpA). We set to evaluate the risk of anterior uveitis (AU) with biologics and synthetic disease-modifying drugs in AxSpA....
7.
Nagra D, Bechman K, Adas M, Yang Z, Alveyn E, Subesinghe S, et al.
Vaccines (Basel)
. 2023 Nov;
11(11).
PMID: 38006012
Background: Pneumococcal pneumonia is an important cause of morbidity and mortality amongst patients with inflammatory arthritis. Vaccination is recommended by the National Institute for Health and Care Excellence (NICE) but...
8.
Russell M, Ameyaw-Kyeremeh L, DellAccio F, Lapham H, Head N, Stovin C, et al.
Rheumatology (Oxford)
. 2023 Nov;
63(8):2222-2229.
PMID: 37929968
Objectives: To evaluate a strategy designed to optimize care and increase uptake of urate-lowering therapy (ULT) during hospitalizations for gout flares. Methods: We conducted a prospective cohort study to evaluate...
9.
Yates M, Bechman K, Adas M, Wright H, Russell M, Nagra D, et al.
J Rheumatol
. 2023 May;
50(9):1178-1184.
PMID: 37188382
Objective: Online patient-reported outcome measures (PROMs) enable remote collection of perceptions of health status, function, and well-being. We aimed to explore patterns of PROM completion in patients with early inflammatory...
10.
Nagra D, Russell M, Alveyn E, Birring S, Elias D, Balachandran S, et al.
Rheumatology (Oxford)
. 2022 Dec;
62(7):e221-e222.
PMID: 36519831
No abstract available.